Literature DB >> 31782043

Awareness campaigns of atrial fibrillation as an opportunity for early detection by pharmacists: an international cross-sectional study.

Filipa Alves da Costa1,2, Katerina Mala-Ladova3, Vivian Lee4, Salvador Tous5, John Papastergiou6, Dale Griffiths7, Marie-Camille Chaumais8, Kurt E Hersberger9, Reka Viola10, Ema Paulino11, Trudie Lobban12, Lis Neubeck13, Ben Freedman14, Sotiris Antoniou15.   

Abstract

Atrial fibrillation (AF) accounts for up to one third of strokes, one of the lead mortality causes worldwide. The European Society of Cardiology guidelines recommend opportunistic screening as a means to increase the odds of early detection and institution of appropriate treatment according to risk factors identified. However, in most countries there are various barriers to effective uptake of screening, including low awareness. The Atrial Fibrillation Association is a patient association engaged with raising awareness of AF. Establishing a partnership with the International Pharmacists for Anticoagulation Care Taskforce, we set as goals to test a model for raising awareness of AF involving pharmacists globally; and to identify barriers and enablers to its implementation. A cross-sectional study was conducted during the Arrhythmia Alliance World Heart Rhythm Week. Pharmacists from 10 countries invited individuals (≥ 40 years; without anticoagulation therapy of AF) to participate in the awareness campaign. Participants agreeing were engaged in the early detection of AF (EDAF) using pulse palpation. Individuals with rhythm discrepancies were referred and prospectively assessed to have information on the proportion of confirmed diagnosis, leading to estimate the detection rate. Interviews with country coordinators explored barriers and enablers to implementation. The study involved 4193 participants in the awareness campaign and 2762 in the EDAF event (mean age 65.3 ± 13.0), of whom 46.2% individuals were asymptomatic, recruited across 120 sites. Most common CHA2DS2-VASc risk factor was hypertension. Among 161 patients referred to physician, feedback was obtained for 32 cases, of whom 12 new arrhythmia diagnoses were confirmed (5 for AF, 2 for atrial flutter), all among elders (≥ 65 years). Qualitative evaluation suggested a local champion to enable pharmacists' success; technology enhanced engagement amongst patients and increased pharmacists' confidence in referring to physicians; interprofessional relationship was crucial in success. This study suggests pharmacists can contribute to greater outreach of awareness campaigns. Effective communication pathways for inter-professional collaboration were suggested enablers to gain full benefits of EDAF.

Entities:  

Keywords:  Atrial fibrillation; Awareness; Early detection of disease; Pharmacists; Pulse check

Year:  2020        PMID: 31782043     DOI: 10.1007/s11239-019-02000-x

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  25 in total

1.  Prevalence of atrial fibrillation in adults participating in a large-scale voluntary screening programme in Belgium.

Authors:  Neree Claes; Christophe Van Laethem; Marnix Goethals; Peter Goethals; Georges Mairesse; Bruno Schwagten; Dieter Nuyens; Ward Schrooten; Johan Vijgen
Journal:  Acta Cardiol       Date:  2012-06       Impact factor: 1.718

2.  Identification of patients with atrial fibrillation in UK community pharmacy: an evaluation of a new service.

Authors:  M J Twigg; T Thornley; N Scobie
Journal:  Int J Clin Pharm       Date:  2016-04-23

3.  Constructing Grounded Theory: A practical guide through qualitative analysis Kathy Charmaz Constructing Grounded Theory: A practical guide through qualitative analysis Sage 224 £19.99 0761973532 0761973532 [Formula: see text].

Authors: 
Journal:  Nurse Res       Date:  2006-07-01

4.  Screening for atrial fibrillation above age 65 detects an asymptomatic subset at high risk of stroke.

Authors:  Bishoy Deif; Nicole Lowres; Saul Benedict Freedman
Journal:  Int J Cardiol       Date:  2012-09-07       Impact factor: 4.164

5.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Authors:  Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas
Journal:  Eur Heart J       Date:  2016-08-27       Impact factor: 29.983

6.  A community pharmacist-led anticoagulation management service: attitudes towards a new collaborative model of care in New Zealand.

Authors:  John Shaw; Jeff Harrison; Jenny Harrison
Journal:  Int J Pharm Pract       Date:  2014-02-24

Review 7.  Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE).

Authors:  Georges H Mairesse; Patrick Moran; Isabelle C Van Gelder; Christian Elsner; Marten Rosenqvist; Jonathan Mant; Amitava Banerjee; Bulent Gorenek; Johannes Brachmann; Niraj Varma; Gustavo Glotz de Lima; Jonathan Kalman; Neree Claes; Trudie Lobban; Deirdre Lane; Gregory Y H Lip; Giuseppe Boriani
Journal:  Europace       Date:  2017-10-01       Impact factor: 5.214

8.  iPhone ECG screening by practice nurses and receptionists for atrial fibrillation in general practice: the GP-SEARCH qualitative pilot study.

Authors:  Jessica Orchard; Saul Benedict Freedman; Nicole Lowres; David Peiris; Lis Neubeck
Journal:  Aust Fam Physician       Date:  2014-05

9.  Economic analysis of the diabetes and hypertension screening collaboration between community pharmacies and a Thai government primary care unit.

Authors:  Phayom Sookaneknun; Kritsanee Saramunee; Ruchilak Rattarom; Suratchada Kongsri; Ratana Senanok; Pongpan Pinitkit; Wathana Sawangsri; Bhudtharat Deesin
Journal:  Prim Care Diabetes       Date:  2010-06-16       Impact factor: 2.459

10.  Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study.

Authors:  Emma Svennberg; Johan Engdahl; Faris Al-Khalili; Leif Friberg; Viveka Frykman; Mårten Rosenqvist
Journal:  Circulation       Date:  2015-04-24       Impact factor: 29.690

View more
  5 in total

1.  Direct oral anticoagulants are effective and safe in the treatment of venous thromboembolism and atrial fibrillation in morbidly obese patients.

Authors:  Mouhand F H Mohamed; Hazem Elewa; Mahmood Mubasher; Mohammed Danjuma
Journal:  J Thromb Thrombolysis       Date:  2021-04       Impact factor: 2.300

2.  Safety and Efficacy of Rivaroxaban and Apixaban in Patients with Increased Body Mass: a Systematic Review.

Authors:  Margaret M Buck; Alexa M Haddon; Antonietta Paneccasio; Daniel J Skoloda; David E Zimmerman; Anthony J Guarascio; Branden D Nemecek; Jordan R Covvey; Courtney A Montepara
Journal:  Clin Drug Investig       Date:  2021-03-07       Impact factor: 2.859

3.  Development and testing of a framework for defining a strategy to address medication adherence during patient encounters in community pharmacies.

Authors:  Pascal C Baumgartner; Nicolas Comment; Kurt E Hersberger; Isabelle Arnet
Journal:  Explor Res Clin Soc Pharm       Date:  2022-03-09

4.  A qualitative exploration of mental health services provided in community pharmacies.

Authors:  Carmen Crespo-Gonzalez; Sarah Dineen-Griffin; John Rae; Rodney A Hill
Journal:  PLoS One       Date:  2022-05-12       Impact factor: 3.752

5.  Pharmacy-Based Opportunistic Atrial Fibrillation Screening at a Community Level: A Real-Life Study.

Authors:  Stephane Olindo; Pauline Renou; François Martial; Nathalie Heyvang; Lea Milan; Sylvain Ledure; François Rouanet
Journal:  Healthcare (Basel)       Date:  2022-01-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.